DUBLIN--(BUSINESS WIRE)--The "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global nuclear medicine/radiopharmaceutical market is expected to reach $9,275.3 million by 2022.
Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy.
The SPECT and PET diagnostics market is further divided into isotopes and application. SPECT market by isotopes includes technetium (Tc-99m), thallium (Tl-201), gallium (Ga-67), iodine (I-123), samarium (Sm-153), yttrium (Y-90), rhenium (Re-186) and others. SPECT by applications are classified into cardiology, gastrointestinal, oncology, nephrology, neurology, inflammation, thyroid glands, lymphology and others. The PET diagnostic market by isotopes involves fluorodeoxyglucose (18f-FDG), gallium (Ga-68), rubidium (Rb-82) and others. PET applications are segmented into cardiology, oncology, neurology, inflammation, thyroid and others.
The alpha radiation therapy includes actinium (Ac-225), astatine-211 (At-211), lead (Pb-212)/bismuth (Bi-212), radium (Ra-223), radium-224 (Ra-224), thorium-227 (Th-227) and others. The isotopes considered in beta radiation therapy are erbium (Er-169), iodine (I-131), lutetium (Lu-177), rhenium (Re-186), samarium (Sa-153), strontium (Sr-89), yttrium (Y-90) and others. The final therapeutic segment brachytherapy involves cesium (Cs-131), iodine (I-125), iridium (Ir-192), palladium (Pd-103) and others.
The nuclear medicine market end-users include medical, academic research laboratories and industries. The end-users by medical further segmented into hospitals and diagnostic centers.
The nuclear medicine/radiopharmaceutical market includes stable isotopes section as well which is classified into isotopes and applications. Isotopes considered are carbon (C-13), deuterium (D2), oxygen (O-18), nitrogen (N-15), sulphur (S-32) and others. The stable isotopes have application in diagnostics and therapy, pharmaceutical companies, research section and industrial sector. The leading players of this market are Cambridge Isotope Laboratories (U.S.) and Isotec Inc. subsidiary of Sigma Aldrich (U.S.).
The nuclear medicine/radiopharmaceuticals market is expected to grow at single digit CAGR during 2015 to 2022. The factors driving the growth of this market are increased application of radiopharmaceuticals, rise in public awareness, usage of hybrid imaging, abundance of radiopharmaceuticals, technological advancements; alpha radioimmunotherapy based targeted cancer treatment and wide range of available products likely to propel the nuclear medicine market.
In addition to this, increasing need in emerging markets, production of radiopharmaceuticals from cyclotrons, efficient diagnosis and treatments, emerging radioisotopes, increasing therapeutic application areas and replacement of old/traditional equipment are some of the opportunities that are propelling the growth of the market. However, regulatory issues, high cost and supply shortage of isotopes, shorter half life of radiopharmaceuticals, and threat from traditional/alternative diagnostic procedures are hampering the growth of the market.
The threats for the nuclear medicine/radiopharmaceuticals market include huge capital investment and shortage of qualified technicians. The major problem area of nuclear medicine market is closure of reactors.
The nuclear medicine/radiopharmaceuticals global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.
Key Topics Covered:
1 Executive Summary
3 Market Analysis
4 Nuclear Medicine Global Market, By Modality
5 Nuclear Medicine Global Market, By End-Users
6 Stable Isotopes
7 Regional Analysis
8 Competitive Landscape
9 Major Player Profiles
- Ablynx Nv
- Abx Gmbh
- Actinium Pharmaceuticals, Inc
- Advanced Accelerator Applications
- Advanced Medical Isotope Corporation
- Affibody Ab
- Algeta Asa
- Areva Med
- Auspex Pharmaceuticals
- Bard Medicals
- Bavarian Nordic
- Bayer Healthcare
- Best Medical International, Inc
- Bio Analytical Research Corporation Laboratories
- Bracco Diagnostics Incs
- Btg International Ltd
- Bv Cyclotron Vu
- Cambridge Isotope Laboratories Inc.
- Cardinal Health Inc.
- Cellectar Biosciences
- Centre For Probe Development And Commercialization
- China Isotope Corporation
- Clarity'S Pharmaceuticals
- Coqui Pharmaceuticals
- Cp Medical
- Digirad Corporation
- Draximage Inc.
- Eckert & Ziegler Strahlen
- Eden Radioisotopes Llc
- Eli Lilly & Co
- Fujifilm Corporation
- Ge Healthcare
- Huayi Isotopes Co
- Iba Group
- Idb Holland Bv
- Industrial Nuclear Company
- International Isotopes Inc.
- Invap S.E
- Iso Ray Medical Inc
- Iso Therapeutics Group, Llc
- Iso-Analytical Ltd
- Isoaid Llc
- Isoflex Isotope
- Isorad Ltd
- Isotec Inc
- Isotope Technologies Garching
- Ithemba Labs
- Joint Stock Company Isotope
- Lantheus Medical Imaging Inc
- Linde Group
- Mallinckrodt Plc
- Medi-Physics, Inc
- Medical Isotopes, Inc
- Mediso Medical Imaging Systems
- Memorial Sloan Kettering Cancer Center
- Navidea Biopharmaceuticals Inc
- Nihon Medi Physics Co Ltd
- Nordion Inc.
- Northstar Medical Technologies
- Ntp Radioisotopes Soc Ltd
- Octreopharm Sciences Gmbh
- Ostuka Pharmaceuticals Co Ltd
- Pars Isotope
- Peregrine Pharmaceuticals, Inc
- Perkin Elmer
- Perma-Fix Medical Sa
- Petnet Solution
- Philips Health Care
- Positron Corporation
- Radiomedix, Inc.
- Rotem Medical
- Royal Philips Electronics
- Sercon Australia Pvt Ltd
- Sercon Ltd
- Shangai Research Institute Of Chemical Industry
- Shine Medical Technologies, Inc
- Siemens Healthcare
- Source Production And Equipment Company
- Spectrum Pharmaceuticals, Inc
- Spepharm Ag
- Stb Isotope Germany Gmbh
- Sterigenics International
- Tayyo Nippon Sanso Corporation
- Theragenics Corporation
- Thermo Fisher Scientific
- Toshiba Medical Systems Corporation
- Trigon Biotechnology Inc
- Westinghouse Electric Company
- Zevacor Molecular
For more information about this report visit https://www.researchandmarkets.com/research/wlkj7t/global_nuclear?w=4
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.